Funded Tech Companies
Proteostasis Therapeutics
Headquartered in Boston, Proteostasis Therapeutics has funding from private investors, Sanofi-Genzyme BioVentures and Novartis BioVenture Fund.
Company Overview
Company Name
Proteostasis Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
80 Guest St. 5th Floor
Boston, MA 02135
USA
Boston, MA 02135
USA
Phone
Website
Email Address
Company Background Information
Overview
Proteostasis Therapeutics (NASDAQ: PTI) is discovering and developing novel small molecule therapeutics designed to control the body's Proteostasis Network, which maintains the body's natural protein homeostasis to protect us from numerous diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/12/2016
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Meenu Chhabra
Chief Medical Officer
Po-Shun Lee
Chief Operating Officer
Marija Zecevic
Chief Scientific Officer
Ben Munoz
VP - Bus. Development
Geoffrey Gilmartin
VP - Operations
Sheila Wilson
Company Investors
- Sanofi-Genzyme BioVentures
- Novartis BioVenture Fund
- Novartis Venture Fund (Lauren Silverman)
- New Enterprise Associates (James Barrett)
- Rock Springs Capital
- HealthCare Ventures (Christopher Mirabelli)
- F-Prime Capital (Stephen Knight)
- Cormorant Asset Management (Bihua Chen)
- Genzyme Ventures (Alan Walts)
- Novartis BioVenture Fund (Lauren Silverman)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs